Both oral and transdermal estrogen increase growth hormone release in postmenopausal women - A clinical research center study

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 6, 1996, Pages 2250-2256

  Friend, Keith E ^a   Hartman, Mark L ^a   Pezzoli, Suzan S ^a   Clasey, Jody L ^a   Thorner, Michael O ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; GROWTH HORMONE; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; CHEMILUMINESCENT MEASUREMENTS; ESTRADIOL; ESTRONE; FEMALE; GONADOTROPINS; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; MIDDLE AGED; POSTMENOPAUSE; PULSATILE FLOW; SEX HORMONE-BINDING GLOBULIN;

EID: 0030011106     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.6.2250     Document Type: Article

References (32)

1. Ho KY, Evans WS, Blizzard RM, et al. 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 64:51-58.
2. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP. 1981 Impaired growth hormone secretion in the adult population. Relation to age and adiposity. J Clin Invest. 67:1361-1369.
3. Rudman D, Feller AG, Hoskote S, et al. 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med. 323:1-6.
4. Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. 1980 Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med. 303:1195-1198.
5. Dawson-Hughes B, Stem D, Goldman J, Reichlin S. 1986 Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement. J Clin Endocrinol Metab. 63:424-432.
6. Weissberger AJ, Ho KKY, Lazarus L. 1991 Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor 1, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 72:374-381.
7. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KKY. 1993 Effects of different oral estrogen formulations on insulin-like growth factor-1, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol (Oxf). 39:561-567.
8. Bellantoni MF, Harman SM, Cho DE, Blackman MR. 1991 Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-1 in postmenopausal women of different ages. J Clin Endocrinol Metab. 72:172-178.
9. Slowinska-Srzednicka J, Zgliczynski S, Jeske W, et al. 1992 Transdermal 17β-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-1 in postmenopausal women. J Endocrinol Invest. 15:533-538.
10. Chetkowski RJ, Meldrum DR, Steingold KA, et al. 1986 Biologic effects of transdermal estradiol. N Engl J Med. 314:1615-1620.
11. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO. 1994 Enhanced sensitivity growth hormone chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab. 78:1312-1319.
12. Hyrb DJ, Khan MS, Romas NA, Rosner W. 1989 Solubilization and partial characterization of the sex hormone-binding globulin receptor from human prostate. J Biol Chem. 264:5378-5383.
13. Straume ML, Veldhuis JD, Johnson ML. 1994 Model-independent quantification of measurement error: empirical estimation of discrete variance function profiles based on standard curves. Methods Enzymol. 240:121-150.
14. Veldhuis JD, Johnson ML. 1986 Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol. 250:E486-E493.
15. Straume M, Veldhuis JD, Johnson ML. 1995 Realistic emulation of highly irregular temporal patterns of hormone release: a computer-based pulse simulator. In: Johnson ML and Veldhuis JD, eds. Methods in Neuroscience. Orlando, FL: Academic Press. 28:220-243.
16. Iranmanesh A, Grisso B, Veldhuis JD. 1994 Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab. 78:526-535.
17. Veldhuis JD, Moorman J, Johnson ML. 1994 Deconvolution analysis of neuroendocrine data: waveform-specific and waveform-independent methods and applications. In: Johnson ML, Veldhuis JD, eds. Methods in Neuroscience. Orlando, FL: Academic Press. 20:279-325.
18. Powers MS, Schenkel L, Darley PE, Good WR, Balestra JC, Place VA. 1985 Pharmacokinetcs and pharmacodynamics of transdermal dosage forms of 17β-estradiol: comparison with conventional oral estrogens used for hormone replacement. Am J Obstet Gynecol. 152:1099-1106.
19. Faria AC, Bekenstein LW, Booth RA, et al. 1992 Pulsatile growth hormone release in normal women during the menstrual cycle. Clin Endocrinol (Oxf). 36:591-596.
20. Berelowitz M, Szabo M, Froman LA, Firestone S, Chu L, Hintz RL. 1981 Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and pituitary. Science. 212:1279-1281.
21. Yamashita S, Melmed S. 1986 Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels. Endocrinology. 118:176-182.
22. Aguila MC, Boggaram V, McCann SM. 1993 Insulin-like growth factor I modulates hypothalamic somatostatin through a growth hormone releasing factor increased somatostatin release and messenger ribonucleic acid levels. Brain Res. 625:213-218.
23. Plotsky PM, Vale W. 1985 Pattern of growth hormone releasing factor and somatostatin secretion into the hypophyseal-portal circulation of the rat. Science. 220:77-79.
24. Tannenbaum GS 1989 Interrelation of growth hormone releasing hormone and somatostatin in the regulation of growth hormone secretion. In: Freich H, Thorner MO, eds. Hormonal regulation of growth. New York: Raven Press; 1-17.
25. Frohman LA, Downs TR, Clarke IJ, Thomas GB. 1990 Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. Spontaneous secretion and response to insulin-induced hypoglycemia. J Clin Invest. 86:17-24.
26. Hartman ML, Clayton PE, Johnson ML, et al. 1993 A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest. 91:2453-2462.
27. Friend KE, Chiou YK, Lopes MBS, Laws Jr ER, Hughes KM, Shupnik MA. 1994 Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas. J Clin Endocrinol Metab. 78:1497-1504.
28. Kimura N, Hayafuji C, Komagaya K, Takahashi K. 1986 17-B-estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells. Endocrinology. 119:1028-1036.
29. Epelbaum J, Agid F, Agid Y, et al. 1988 Somatostatin receptors in brain and pituitary. Horm Res. 31:45-50.
30. Herbison AE, Theodosis DT. 1993 Absence of estrogen receptor immunoreactivity in somatostatin (SRIF) neurons of the periventricular nucleus but sexually dimorphic colocalization of estrogen receptor and SRIF immunoreactivities in neurons of the bed nucleus of the stria terminalis. Endocrinology. 132:1707-1714.
31. Slama A, Videau C, Kordon C, Epelbaum J. 1992 Estradiol regulation of somatostatin receptors in the arcuate nucleus of the female rat. Neuroendocrinology. 56:240-245.
32. Hartman ML, Pincus SM, Johnson ML, et al. 1994 Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release. J Clin Invest. 94:1277-1288.